Le Lézard
Classified in: Health, Business
Subject: TNM

DW Healthcare Partners Announces Sale of Reliant Rehabilitation


PARK CITY, Utah, Sept. 13, 2018 /CNW/ -- DW Healthcare Partners ("DWHP"), a healthcare-focused private equity firm, announced the sale of its portfolio company, Reliant Rehabilitation ("Reliant" or the "Company"), to H.I.G. Capital LLC. Headquartered in Plano, TX, Reliant is one of the leading providers of contract therapy services to post-acute facilities in the United States. Using proprietary clinical models, Reliant provides the highest levels of care with more than 30,000 patient encounters each day across more than 800 therapy sites.

DW Healthcare Partners Logo

Chris Bird, Chief Executive Officer of Reliant, commented, "Reliant has grown exceptionally well under DWHP's stewardship. We look forward to the next phase in Reliant's development as we continue to help our clients navigate the changes in post-acute markets while delivering best-in-class care for our patients."

Doug Schillinger, Managing Director at DWHP added, "Since its founding, Reliant has consistently done well because of leadership's unfettered commitment to the clinical staff and their absolute dedication to the patients they serve. We have every confidence they will continue to improve countless lives."

Deutsche Bank served as financial advisor to DWHP on the transaction. Paul Hastings LLP served as DWHP's legal counsel.

ABOUT DW HEALTHCARE PARTNERS
DW Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. The firm manages over $800 million in committed capital and invests in profitable healthcare companies with proven management teams.

DW Healthcare Partners is led by seasoned healthcare executives with more than 110 years of combined industry experience. The firm provides the capital, strategic guidance, and acquisition expertise to help mid-to-late-stage companies realize their potential for growth.

For more information, please contact:
Lisa Downey
416-583-2428
[email protected]

 

SOURCE DW Healthcare Partners


These press releases may also interest you

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Galantas Gold Corporation (the ?Company') is pleased to announce its audited annual financial results for the year ended December 31, 2023. A copy of the Financial Statements and Management Discussion and Analysis will be sent to shareholders in due...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
ICEYE, a global leader in satellite-powered disaster management solutions, has announced a new data collaboration with Juniper Re, LLC ("Juniper Re"), the dynamic reinsurance broking arm and indirect subsidiary of BRP Group, Inc. . Juniper Re will...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...



News published on and distributed by: